Showing results (1491-1500 of 1,776) with videos related to
Sort By:
Pageof 178
Cancer Research|July 19, 2002
Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study GroupFredrik Mertens, Ulf Strömberg, Nils Mandahl, et al.International Journal of Surgical Pathology|June 21, 2002
Diagnosis of gastrointestinal stromal tumors: a consensus approachChristopher D M Fletcher, Jules J Berman, Christopher Corless, et al.Heart, Lung & Circulation|December 17, 2022
Cryoprecipitate Transfusion After Cardiac SurgeryJake V Hinton, Zhongyue Xing, Calvin M Fletcher, et al.Annals of Neurology|January 6, 2004
De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiencyRobert McFarland, Denise M Kirby, Kerry J Fowler, et al.Nitric Oxide : Biology and Chemistry|July 31, 2012
Nitrate reductase activity of bacteria in saliva of term and preterm infantsJesica A Kanady, A Wilson Aruni, Janet R Ninnis, et al.Biological Psychiatry|July 5, 2003
Neural systems for compensation and persistence: young adult outcome of childhood reading disabilitySally E Shaywitz, Bennett A Shaywitz, Robert K Fulbright, et al.Journal of Clinical Gastroenterology|April 18, 2020
Induction of Meal-related Symptoms as a Novel Mechanism of Action of the Duodenal-Jejunal Bypass SleeveJessica J McMaster, Graeme G Rich, Erin R Shanahan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumorsAndrew J Wagner, Izabela Malinowska-Kolodziej, Jeffrey A Morgan, et al.Cloning and Stem Cells|January 2, 2007
Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell linesJudy M Fletcher, Patricia M Ferrier, John O Gardner, et al.Molecular Therapy. Oncology|September 18, 2024
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancerGhassan M Saed, Nicole M Fletcher, Harvey Sharma, et al.Pageof 178